BriaCell Therapeutics Corp. (BCTX) bonds
BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
$3.39−0.12 (-3.42%)
Close on Nov 13, 2026Market cap $29.60MP/E –Yield –
Debt
Borrowings on the balance sheet, Jul 31, 2026
BriaCell Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in BriaCell Therapeutics's 10-K for the period ended Dec 31, 2020
| Issue | Coupon | Amount issued |
|---|---|---|
| Canada Emergency Business Account Loan | 15.00% | $25.99K |
| Paycheck Protection Program | 1.00% | – |
| Unsecured Convertible Debenture Convertible | – | $305.25K |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.
See a number that looks wrong?